X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ELDER PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ELDER PHARMA STERLING BIOTECH/
ELDER PHARMA
 
P/E (TTM) x -0.4 -0.2 - View Chart
P/BV x 0.0 0.1 16.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   ELDER PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ELDER PHARMA
Jun-14
STERLING BIOTECH/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs11380 2.8%   
Low Rs3188 1.8%   
Sales per share (Unadj.) Rs26.8491.2 5.5%  
Earnings per share (Unadj.) Rs-15.0-3.2 470.1%  
Cash flow per share (Unadj.) Rs-5.514.4 -37.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9376.5 14.6%  
Shares outstanding (eoy) m267.8720.54 1,304.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.6 44.8%   
Avg P/E ratio x-0.5-89.3 0.5%  
P/CF ratio (eoy) x-1.319.7 -6.5%  
Price / Book Value ratio x0.10.8 16.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8625,833 31.9%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5472,179 25.1%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18110,089 71.2%  
Other income Rs m43257 16.6%   
Total revenues Rs m7,22310,346 69.8%   
Gross profit Rs m947-792 -119.6%  
Depreciation Rs m2,543361 703.9%   
Interest Rs m4,3772,756 158.8%   
Profit before tax Rs m-5,931-3,653 162.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m-1,924125 -1,537.6%   
Profit after tax Rs m-4,007-65 6,130.8%  
Gross profit margin %13.2-7.8 -168.0%  
Effective tax rate %32.4-3.4 -947.0%   
Net profit margin %-55.8-0.6 8,614.0%  
BALANCE SHEET DATA
Current assets Rs m14,3359,240 155.1%   
Current liabilities Rs m49,8099,998 498.2%   
Net working cap to sales %-494.0-7.5 6,578.2%  
Current ratio x0.30.9 31.1%  
Inventory Days Days40346 871.1%  
Debtors Days Days17160 284.7%  
Net fixed assets Rs m55,43210,124 547.5%   
Share capital Rs m268206 130.2%   
"Free" reserves Rs m13,9355,582 249.6%   
Net worth Rs m14,7017,734 190.1%   
Long term debt Rs m9,4784,889 193.9%   
Total assets Rs m73,98822,882 323.3%  
Interest coverage x-0.4-0.3 109.1%   
Debt to equity ratio x0.60.6 102.0%  
Sales to assets ratio x0.10.4 22.0%   
Return on assets %0.511.8 4.3%  
Return on equity %-27.3-0.8 3,225.1%  
Return on capital %-6.422.3 -28.8%  
Exports to sales %25.93.0 852.3%   
Imports to sales %0.20.4 39.8%   
Exports (fob) Rs m1,860307 606.6%   
Imports (cif) Rs m1243 28.3%   
Fx inflow Rs m1,860307 606.6%   
Fx outflow Rs m25125 19.9%   
Net fx Rs m1,835181 1,012.1%   
CASH FLOW
From Operations Rs m1,71911,754 14.6%  
From Investments Rs m-3,148-561 561.7%  
From Financial Activity Rs m1,426-6,762 -21.1%  
Net Cashflow Rs m-34,432 -0.1%  

Share Holding

Indian Promoters % 33.9 39.6 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 9.9 16.8 58.9%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 36.1 108.9%  
Shareholders   21,482 16,479 130.4%  
Pledged promoter(s) holding % 55.9 77.6 72.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   MERCK LTD  IPCA LABS  ASTRAZENECA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Metal & Realty Stocks Gain(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.2% while the Hang Seng is down 1%.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 13, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS